• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Technology

Royvant Bets on Hanol’s IMVT-1402… “GD New Drug to Launch Ahead of Competitors”

Royvant is focusing its funding and development capabilities on IMVT-1402 (active ingredient: imeropruvate), a next-generation FcRn antibody licensed from HANALL BIOPHARMA CO.,LTD(009420). This comes …
  • 2026-08-14 08:36:02
  • NA EUN-KYUNG
Lifestyle

JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns [K-Bio Pulse]

South Korean pharmaceutical and biotech stocks traded lower across the board, with #JW Pharmaceutical and #OliX Pharmaceuticals drawing particular attention. JW Pharmaceutical surged nearly 15% as suc…
  • 2026-08-14 08:06:03
  • SONG YOUNG-DOO
Lifestyle

JWPHARMACEUTICAL Jumps 16% on Phase 3 Success... Why Did 'Positive News' Olix Pharmaceuticals, Inc. Plunge 11%? [Bio Spotlight]

While domestic pharmaceutical and biotech stocks were generally weak, JWPHARMACEUTICAL(001060)and Olix Pharmaceuticals, Inc.(226950)drew attention. JWPHARMACEUTICAL surged more than 16% as the success…
  • 2026-08-14 08:06:02
  • SONG YOUNG-DOO
Technology

Korean Dental Stocks Rally on M&A and Strong Earnings [K-Bio Pulse]

Shares of dental-related companies rallied in South Korea’s pharmaceutical, biotech, and healthcare market on Aug. 11, buoyed by expectations for business expansion and strong earnings.South Korea’s d…
  • 2026-08-13 07:52:04
  • NA EUN-KYUNG
Technology

Graphy Inc., Backed by Ray Co., Ltd.; Value Added Technology Co., Ltd. Posts Surprise Earnings… K-Dental Stocks Rise in Tandem [Bio Spotlight]

On the 11th, stock prices of listed companies in the dental sector rose across the board in the domestic pharmaceutical, biotech, and healthcare market. The domestic dental industry has established a …
  • 2026-08-13 07:52:03
  • NA EUN-KYUNG
Technology

FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Hopes for Follow-On Licensing [K-Bio Pulse]

On August 10, South Korean pharmaceutical and biotech stocks rose across the board as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock…
  • 2026-08-12 08:02:04
  • Minji Son
Technology

From Bio Co., Ltd. Hits Daily Limit Up as Trading Resumes… curacle co., ltd. Also Surges on Expectations of ‘Follow-up Technology Transfer’ [Bio Spotlight]

On the 10th, domestic pharmaceutical and biotech stocks showed an overall upward trend, buoyed by a rebound in the KOSDAQ index. From Bio Co., Ltd.(377220), which resumed trading that day after comple…
  • 2026-08-12 08:02:02
  • Minji Son
Technology

Coreline Soft Co., Ltd. Brings AI to U.S. Hospital Reading Rooms… Expanding Commercial Workflow in North America

Coreline Soft Co., Ltd.(384470)has supplied medical artificial intelligence (AI) to a 651-bed regional academic medical center in the U.S. and began using it for actual patient diagnoses last month. T…
  • 2026-08-11 12:02:02
  • NA EUN-KYUNG
Lifestyle

Laseroptek Co., Ltd. CEO Lee Chang-jin: "Double-Digit Operating Profit Margin by 2027 with Bascula 589"

In the global market for laser medical devices used in dermatological aesthetics and treatment, South Korea’s first-generation solid-state laser venture, Laseroptek Co., Ltd.(199550), is leading a par…
  • 2026-08-11 08:42:02
  • YU JIN-HEE
Technology

[The Era of Oral Weight-Loss Drugs, Part 1] Following the U.S. and the EU, South Korea Is on the Verge of Launch… Key Issues Regarding Insurance Coverage and Prescriptions

The center of gravity in the obesity treatment market is shifting rapidly. As oral glucagon-like peptide-1 (GLP-1) drugs are being commercially launched one after another in the United States and the …
  • 2026-08-11 08:12:02
  • Kim Seung-kwon
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English